"On receipt of confidential information that some medical devices are being stocked at 3rd floor of GT Hospital, Mumbai, the team of FDA, Mumbai, on Thursday raided the premises," he said.
"It was found that one Vineet Tukaram Pimpale was operating from the premises in the name of M/s. Medicol Surgical & Hospital Equipment. The firm was operating without license. Stock of various orthopedic implants, including Intramedulary Nails and Interlocking Bolts were seized from the premises," the senior IAS official said.
"An FDA team raided the premises of M/s Asclepious Enterprises, Ganesh Nagar, Nanded. The firm was not holding licenses for stock and sale of medical devices. Various orthopedic implants, worth Rs 1.07 crore were seized from the premises.
"The medical devices seized include Acetabular Cups, Shoulder Prosthesis rods, Muller Stem, Biopolar Hip Cross, Cancellous, Angle Radius, Poesteriomedial Tibia, Distal Tibia Nails, Cortex, Platonic Stem, Syrus Femur Nails, etc. These devices include some sterile implants to be used in orthopedic operations.
"The implants are used in Hip Replacement surgeries, Hip Joints procedures, fractures, etc. Despite operating without licence M/s Asclepious Enterprises was appointed as authorized dealer for Maharashtra by manufacturers namely M/s. Sharma Surgical & Engineering Pvt. Ltd., Vadodara, Gujarat and Orthotech Implants with Confidence, Valsad, Gujarat.
This is the first time such a big raid has been carried out by FDA, he said.
"Rules prohibit stock, distribute and sale of the medical devices, except under licence issued under Drugs and Cosmetics Rules, 1945. This offence attracts penalty of imprisonment of 3 to 5 years and fine of minimum Rs 1 lakh, he said.
"Investigation revealed that this firm was selling these implants to about 22 various stockiest in Maharashtra. I have issued directions to all Joint Commissioners to carry out checks accordingly. Further investigation is in progress. Samples are being sent to ascertain the quality of the implants," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
